S&P 500   4,394.12 (+1.02%)
DOW   34,595.50 (+1.25%)
QQQ   348.85 (+1.24%)
AAPL   162.90 (+2.01%)
MSFT   305.34 (+2.91%)
FB   301.38 (+2.29%)
GOOGL   2,633.24 (+1.88%)
AMZN   2,871.92 (+3.40%)
TSLA   871.67 (-7.01%)
NVDA   225.30 (-1.06%)
BABA   113.67 (+0.26%)
NIO   21.90 (-3.35%)
AMD   107.01 (-3.34%)
CGC   7.03 (-2.77%)
MU   81.29 (-0.83%)
GE   90.17 (+0.95%)
T   24.35 (+0.41%)
F   19.93 (+0.10%)
DIS   137.38 (+2.83%)
AMC   15.12 (-5.14%)
PFE   54.19 (+2.23%)
ACB   3.90 (-3.94%)
BA   194.57 (+0.15%)
S&P 500   4,394.12 (+1.02%)
DOW   34,595.50 (+1.25%)
QQQ   348.85 (+1.24%)
AAPL   162.90 (+2.01%)
MSFT   305.34 (+2.91%)
FB   301.38 (+2.29%)
GOOGL   2,633.24 (+1.88%)
AMZN   2,871.92 (+3.40%)
TSLA   871.67 (-7.01%)
NVDA   225.30 (-1.06%)
BABA   113.67 (+0.26%)
NIO   21.90 (-3.35%)
AMD   107.01 (-3.34%)
CGC   7.03 (-2.77%)
MU   81.29 (-0.83%)
GE   90.17 (+0.95%)
T   24.35 (+0.41%)
F   19.93 (+0.10%)
DIS   137.38 (+2.83%)
AMC   15.12 (-5.14%)
PFE   54.19 (+2.23%)
ACB   3.90 (-3.94%)
BA   194.57 (+0.15%)
S&P 500   4,394.12 (+1.02%)
DOW   34,595.50 (+1.25%)
QQQ   348.85 (+1.24%)
AAPL   162.90 (+2.01%)
MSFT   305.34 (+2.91%)
FB   301.38 (+2.29%)
GOOGL   2,633.24 (+1.88%)
AMZN   2,871.92 (+3.40%)
TSLA   871.67 (-7.01%)
NVDA   225.30 (-1.06%)
BABA   113.67 (+0.26%)
NIO   21.90 (-3.35%)
AMD   107.01 (-3.34%)
CGC   7.03 (-2.77%)
MU   81.29 (-0.83%)
GE   90.17 (+0.95%)
T   24.35 (+0.41%)
F   19.93 (+0.10%)
DIS   137.38 (+2.83%)
AMC   15.12 (-5.14%)
PFE   54.19 (+2.23%)
ACB   3.90 (-3.94%)
BA   194.57 (+0.15%)
S&P 500   4,394.12 (+1.02%)
DOW   34,595.50 (+1.25%)
QQQ   348.85 (+1.24%)
AAPL   162.90 (+2.01%)
MSFT   305.34 (+2.91%)
FB   301.38 (+2.29%)
GOOGL   2,633.24 (+1.88%)
AMZN   2,871.92 (+3.40%)
TSLA   871.67 (-7.01%)
NVDA   225.30 (-1.06%)
BABA   113.67 (+0.26%)
NIO   21.90 (-3.35%)
AMD   107.01 (-3.34%)
CGC   7.03 (-2.77%)
MU   81.29 (-0.83%)
GE   90.17 (+0.95%)
T   24.35 (+0.41%)
F   19.93 (+0.10%)
DIS   137.38 (+2.83%)
AMC   15.12 (-5.14%)
PFE   54.19 (+2.23%)
ACB   3.90 (-3.94%)
BA   194.57 (+0.15%)
OTCMKTS:XCRT

Xcelerate Stock Forecast, Price & News

$0.06
0.00 (-3.39%)
(As of 01/26/2022 03:43 PM ET)
Add
Compare
Today's Range
$0.05
▼
$0.06
50-Day Range
$0.06
▼
$0.10
52-Week Range
$0.03
▼
$0.17
Volume
159,100 shs
Average Volume
348,394 shs
Market Capitalization
$20.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
5.37
View Price History Chart DataSkip Price History Chart
30 days | 90 days | 365 days | Advanced Chart
Receive XCRT News and Ratings via Email

Sign-up to receive the latest news and ratings for Xcelerate and its competitors with MarketBeat's FREE daily newsletter.


About Xcelerate

Xcelerate, Inc. engages in dental equipment, which develops, manufactures and markets atmospheric water generators for the dental market, home and office use. It provides dental networks for union members. The company was founded on November 26, 1996 and is headquartered in Mauldin, SC.

Headlines

Xcelerate Files Supplemental Information For Removal of Shell Status
January 25, 2022 |  finance.yahoo.com
Short Interest in Xcelerate Inc. (OTCMKTS:XCRT) Declines By 39.1%
January 17, 2022 |  americanbankingnews.com
XCRT Real-Time Quotes
January 13, 2022 |  nasdaq.com
Xcelerate, Inc. Issues Shareholder Update
January 12, 2022 |  finance.yahoo.com
Xcelerate Acquires Controlling Interest in AfiyaSasa Africa
January 3, 2022 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Health services
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:XCRT
Previous Symbol
CUSIP
N/A
CIK
1138586
Web
newudhi.com
Phone
(854) 900-2020
Fax
N/A
Employees
24
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Price-To-Earnings

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A

Miscellaneous

Outstanding Shares
355,446,000
Free Float
N/A
Market Cap
$20.26 million
Optionable
Not Optionable

Company Calendar

Today
1/27/2022
Fiscal Year End
12/31/2022

MarketRank™

Overall MarketRank™

0.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Xcelerate (OTCMKTS:XCRT) Frequently Asked Questions

Are investors shorting Xcelerate?

Xcelerate saw a drop in short interest in December. As of December 31st, there was short interest totaling 4,200 shares, a drop of 39.1% from the December 15th total of 6,900 shares. Based on an average trading volume of 374,500 shares, the short-interest ratio is presently 0.0 days.
View Xcelerate's Short Interest.

Who are Xcelerate's key executives?

Xcelerate's management team includes the following people:
  • Michael F. O'Shea, President, Chief Executive Officer & Director
  • Anja Glisovic, Chief Science Officer

Who are some of Xcelerate's key competitors?

Some companies that are related to Xcelerate include Covalon Technologies (CVALF), Union Dental (UDHI), Verisante Technology (VRSEF), Accelera Innovations (ACNV) and Advanzeon Solutions (CHCR).
View all of XCRT's competitors.

What is Xcelerate's stock symbol?

Xcelerate trades on the OTCMKTS under the ticker symbol "XCRT."

How do I buy shares of Xcelerate?

Shares of XCRT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Xcelerate's stock price today?

One share of XCRT stock can currently be purchased for approximately $0.06.

How much money does Xcelerate make?

Xcelerate has a market capitalization of $20.26 million.

How many employees does Xcelerate have?

Xcelerate employs 24 workers across the globe.

What is Xcelerate's official website?

The official website for Xcelerate is newudhi.com.

Where are Xcelerate's headquarters?

Xcelerate is headquartered at 1700 UNIVERSITY DRIVE SUITE 200, CORAL SPRINGS FL, 33701.

How can I contact Xcelerate?

Xcelerate's mailing address is 1700 UNIVERSITY DRIVE SUITE 200, CORAL SPRINGS FL, 33701. The company can be reached via phone at (854) 900-2020 or via email at [email protected].


This page was last updated on 1/27/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.